Cargando…

Cellular uptake and localization of inhaled gold nanoparticles in lungs of mice with chronic obstructive pulmonary disease

BACKGROUND: Inhalative nanocarriers for local or systemic therapy are promising. Gold nanoparticles (AuNP) have been widely considered as candidate material. Knowledge about their interaction with the lungs is required, foremost their uptake by surface macrophages and epithelial cells. Diseased lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geiser, Marianne, Quaile, Oliver, Wenk, Alexander, Wigge, Christoph, Eigeldinger-Berthou, Sylvie, Hirn, Stephanie, Schäffler, Martin, Schleh, Carsten, Möller, Winfried, Mall, Marcus A, Kreyling, Wolfgang G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660288/ https://www.ncbi.nlm.nih.gov/pubmed/23680060 http://dx.doi.org/10.1186/1743-8977-10-19

Ejemplares similares

Nanoparticle uptake by airway phagocytes after fungal spore challenge in murine allergic asthma and chronic bronchitis
por: Geiser, Marianne, et al.
Publicado: (2014)

Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm silver nanoparticle aerosols in healthy adult rats after a single 1½-hour inhalation exposure
por: Kreyling, Wolfgang G., et al.
Publicado: (2020)

Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration
por: Schleh, Carsten, et al.
Publicado: (2012)

Quantitative biokinetics over a 28 day period of freshly generated, pristine, 20 nm titanium dioxide nanoparticle aerosols in healthy adult rats after a single two-hour inhalation exposure
por: Kreyling, Wolfgang G., et al.
Publicado: (2019)

Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat
por: Semmler-Behnke, Manuela, et al.
Publicado: (2014)

Cytotoxic and proinflammatory effects of PVP-coated silver nanoparticles after intratracheal instillation in rats
por: Haberl, Nadine, et al.
Publicado: (2013)

Deposition and biokinetics of inhaled nanoparticles
por: Geiser, Marianne, et al.
Publicado: (2010)

In vitro and in vivo interactions of selected nanoparticles with rodent serum proteins and their consequences in biokinetics
por: Kreyling, Wolfgang G, et al.
Publicado: (2014)

Pulmonary surfactant is indispensable in order to simulate the in vivo situation
por: Schleh, Carsten, et al.
Publicado: (2013)

Efficient Elimination of Inhaled Nanoparticles from the Alveolar Region: Evidence for Interstitial Uptake and Subsequent Reentrainment onto Airways Epithelium
por: Semmler-Behnke, Manuela, et al.
Publicado: (2007)

Motion and twisting of magnetic particles ingested by alveolar macrophages in the human lung: effect of smoking and disease
por: Möller, Winfried, et al.
Publicado: (2006)

Ultrafine particles cause cytoskeletal dysfunctions in macrophages: role of intracellular calcium
por: Möller, Winfried, et al.
Publicado: (2005)

Subchronic inhalation toxicity of gold nanoparticles
por: Sung, Jae Hyuck, et al.
Publicado: (2011)

How to optimize the benefits of computer assisted sperm analysis in experimental toxicology
por: Schleh, Carsten, et al.
Publicado: (2013)

The future exacerbation and mortality of different inhalation therapies among patients with chronic obstructive pulmonary disease in various GOLD groups: a focus on the GOLD 2017 and GOLD 2023 reports
por: Song, Qing, et al.
Publicado: (2023)

Uptake of pH-Sensitive Gold Nanoparticles in Strong Polyelectrolyte Brushes
por: Kesal, Dikran, et al.
Publicado: (2016)

Evaluating Adverse Effects of Inhaled Nanoparticles by Realistic In Vitro Technology
por: Geiser, Marianne, et al.
Publicado: (2017)

From the infant to the geriatric patient—Strategies for inhalation therapy in asthma and chronic obstructive pulmonary disease
por: Hagmeyer, Lars, et al.
Publicado: (2023)

CFTR Regulates Early Pathogenesis of Chronic Obstructive Lung Disease in βENaC-Overexpressing Mice
por: Johannesson, Bjarki, et al.
Publicado: (2012)

Biokinetics and clearance of inhaled gold ultrasmall-in-nano architectures
por: Mapanao, Ana Katrina, et al.
Publicado: (2020)

Surfactant Protein D modulates allergen particle uptake and inflammatory response in a human epithelial airway model
por: Schleh, Carsten, et al.
Publicado: (2012)

Inhalation Therapy for Stable COPD: 20 Years of GOLD Reports
por: Terry, Paul D., et al.
Publicado: (2020)

Proinflammatory and cytotoxic response to nanoparticles in precision-cut lung slices
por: Hirn, Stephanie, et al.
Publicado: (2014)

Biokinetic datasets of PEI F25-LMW complexed and non-complexed (32)P-siRNA within different lung compartments
por: Lipka, Jens, et al.
Publicado: (2016)

Lack of Association between Inhaled Corticosteroid Use and the Risk of Future Exacerbation in Patients with GOLD Group A Chronic Obstructive Pulmonary Disease
por: Shin, Sun Hye, et al.
Publicado: (2022)

Uptake and depuration of gold nanoparticles in Daphnia magna
por: Skjolding, L. M., et al.
Publicado: (2014)

Factors associated with the prescription of inhaled corticosteroids in GOLD group A and B patients with COPD – subgroup analysis of the Taiwan obstructive lung disease cohort
por: Wei, Yu-Feng, et al.
Publicado: (2015)

LA inhalers for COPD: perceptions/reality of ABCD GOLD tool use
por: Boryushkina, Varvara, et al.
Publicado: (2020)

Biokinetics of subacutely co-inhaled same size gold and silver nanoparticles
por: Lee, Philku, et al.
Publicado: (2023)

Differential Inflammatory Response to Inhaled Lipopolysaccharide Targeted Either to the Airways or the Alveoli in Man
por: Möller, Winfried, et al.
Publicado: (2012)

Biodistribution of gold nanoparticles in mouse lung following intratracheal instillation
por: Sadauskas, Evaldas, et al.
Publicado: (2009)

Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease
por: Tashkin, Donald P, et al.
Publicado: (2018)

Treatment with inhaled corticosteroids in chronic obstructive pulmonary disease
por: Janson, Christer
Publicado: (2020)

The future of inhalation therapy in chronic obstructive pulmonary disease
por: Cazzola, Mario, et al.
Publicado: (2022)

Effect of Disease Severity in Asthma and Chronic Obstructive Pulmonary Disease on Inhaler-Specific Inhalation Profiles Through the ELLIPTA(®) Dry Powder Inhaler
por: Prime, David, et al.
Publicado: (2015)

Growing gold nanostructures for shape-selective cellular uptake
por: Bandyopadhyay, Sulalit, et al.
Publicado: (2018)

Patient preferences for inhaler devices in chronic obstructive pulmonary disease: experience with Respimat(®) Soft Mist(™) Inhaler
por: Hodder, Richard, et al.
Publicado: (2009)

Inhaler Technique and Adherence to Inhaled Medications among Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Vietnam
por: Ngo, Chau Quy, et al.
Publicado: (2019)

Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma
por: Hua, Jian-lan, et al.
Publicado: (2021)

In Vitro Performance of the Wixela Inhub Inhaler Using Severe Chronic Obstructive Pulmonary Disease Patient Inhalation Profiles
por: Shepherd, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6a7j5fnonk1gpnkt2tah198qik